Introduction
Cell polarity is fundamental for cell-fate decision during development as well as for the maintenance of differentiated cells that constitute normal tissues. Tumors are formed by cells that have lost the ability to assemble and create normal tissues. It is therefore reasonable to speculate that defects in cell polarity have an important function in the development of tumors. The majority of human malignant tumors that arise from epithelial tissues are termed carcinomas. Gastric carcinoma is the second and fourth most common form of malignant tumors in male and female individuals, respectively, accounting for 876 000 estimated new cases and 405 000 estimated deaths in the year 2000 (Parkin et al., 2001) . There is accumulating evidence that chronic infection with Helicobacter pylori, a spiral-shaped bacterium that colonizes the gastric mucosa of more than half of the world's human population, has a causative function in the development of gastric carcinoma (Nomura et al., 1991; Parsonnet et al., 1991; Uemura et al., 2001) . Studies on H. pylori-gastric epithelial cell interactions have greatly contributed to our current understanding of H. pylori-triggered mucosal lesions that direct gastric carcinogenesis, pointing to the H. pylori virulence factor CagA (cytotoxin-associated gene A) as a central player in this process (Peek and Blaser, 2002; Hatakeyama, 2004 Hatakeyama, , 2008 .
Translocation of H. pylori CagA into gastric epithelial cells
CagA is a 120B145-kDa H. pylori protein that is encoded by the cagA gene (Covacci et al., 1993; Tummuru et al., 1993) . The cagA gene is localized at one end of the cag pathogenicity island (cag PAI), a 40-kb DNA segment that is considered to be horizontally transferred into the H. pylori genome (Censini et al., 1996; Akopyants et al., 1998) . Whereas almost all of the East Asian H. pylori isolates are cagA-positive, approximately half of the H. pylori strains isolated in Western countries do not carry cag PAI and thus are cagA negative. In addition to CagA, the cag PAI contains B30 putative genes, among which 18 genes encode proteins serving as building blocks of a type IV secretion system. The type IV secretion system forms a syringe-like structure that is capable of penetrating into the cytoplasm of gastric epithelial cells. Infection with cagA-positive H. pylori strains is associated with severe mucosal inflammation that underlies peptic ulceration, atrophic gastritis and gastric carcinoma Kuipers et al., 1995; Parsonnet et al., 1997) .
Following the attachment of cagA-positive H. pylori to the surface of gastric epithelial cells, CagA is delivered from the bacterium into the cytoplasm of host cells through the type IV secretion system (Segal et al., 1999; Asahi et al., 2000; Backert et al., 2000; Odenbreit et al., 2000; Stein et al., 2000) . This process is mediated at least partly through an interaction of H. pylori CagL with integrins (Kwok et al., 2007) . CagL, also encoded by cag PAI, is targeted to the surface of the type IV secretion pili and acts as a specific adhesin that binds to the host integrin a5b1 in an Arg-Gly-Asp (RGD) motifdependent manner. CagL-integrin interaction triggers type IV injection of CagA into gastric epithelial cells. Within the host cells, CagA localizes to the inner surface of the plasma membrane, where it undergoes tyrosine phosphorylation by Src family kinases or Abl kinase (Selbach et al., 2002; Stein et al., 2002; Poppe et al., 2007; Tammer et al., 2007) . The tyrosine phosphorylation site of CagA is characterized by the Glu-Pro-IleTyr-Ala (EPIYA) motif, which is present in multiple numbers in the carboxy-terminal polymorphic region (EPIYA-repeat region) of the protein (Higashi et al., 2002a, b) . On the basis of sequences flanking the EPIYA motifs, four distinct EPIYA segments, EPIYA-A, -B, -C and -D, each of which contains a single EPIYA motif, have been identified in the EPIYA-repeat region (Higashi et al., 2002b (Higashi et al., , 2005 Naito et al., 2006) ( Figure 1 ). The representative CagA proteins of Western H. pylori isolates (Western CagA) possess the EPIYA-A and EPIYA-B segments followed by the EPIYA-C segment. Intriguingly, the EPIYA-C segment, consisting of 34 amino-acid residues, variably multiplies in tandem, mostly from one time to three times, among different Western CagA species as a result of homologous recombination of a 102-bp cagA gene segment encoding EPIYA-C. The representative CagA proteins of H. pylori isolated in East Asian countries (East Asian CagA) also possess the EPIYA-A and EPIYA-B segments but not the repeatable EPIYA-C segment.
Instead, they have a distinct EPIYA-containing sequence, termed the EPIYA-D segment, which is unique to East Asian CagA.
Interaction of CagA with SHP-2 oncoprotein
Upon tyrosine phosphorylation, CagA acquires the ability to interact with the cytoplasmic protein tyrosine phosphatase SHP-2, which possesses two tandemrepeated Src homology-2 (SH2) domains at the N-terminal region (N-SH2 and C-SH2) and a protein tyrosine phosphatase domain at the C-terminal region (Higashi et al., 2002a, b) (Figure 1 ). Binding of tyrosinephosphorylated CagA to the SH2 domains causes a conformational change in SHP-2 that relieves intramolecular inhibition of the phosphatase domain by the N-SH2 domain, resulting in aberrant activation of SHP-2 phosphatase activity. Western and East Asian CagA species, respectively, bind SHP-2 through the tyrosinephosphorylated EPIYA-C and EPIYA-D segments. Notably, SHP-2-binding activity of the EPIYA-D segment is significantly stronger than that of the EPIYA-C segment, rendering East Asian CagA biologically more active than Western CagA (Naito et al., 2006) . SHP-2 has an important function in signal transduction downstream of growth factor/cytokine receptors that promotes cell proliferation, morphogenesis and motility (Neel et al., 2003) . Consequently, expression of CagA in gastric epithelial cells causes morphological transformation termed the hummingbird phenotype, which is characterized by elongated cell shape with Linking epithelial polarity and carcinogenesis by H. pylori CagA M Hatakeyama dramatic cytoskeletal rearrangements (Segal et al., 1999; Higashi et al., 2002a) . An important question is the nature of the substrates that are dephosphorylated by CagA-activated SHP-2 in the morphogenetic activity of CagA. Recently, focal adhesion kinase (FAK) has been identified as one such substrate . FAK has an important function in the regulation of focal adhesions that mediate cell-extracellular matrix interaction. CagA-activated SHP-2 dephosphorylates at the activating tyrosine phosphorylation sites of FAK in gastric epithelial cells. This in turn leads to the downregulation of FAK kinase activity, which is critically involved in the induction of the hummingbird phenotype by CagA. Consistent with the function of SHP-2 in potentiating the Erk microtubule-associated protein (MAP) kinase pathway by both Ras-dependent and Ras-independent mechanisms, CagA also elicits sustained Erk activation, which has an important function in G1 to S phase cell-cycle progression, in gastric epithelial cells (Higashi et al., 2004) .
Disruption of tight junction and the loss of epithelial polarity by CagA
The establishment and maintenance of mammalian epithelial apical-basolateral polarity are mediated by complex interplays among polarity-regulating proteins that include mammalian orthologs of Caenorhabditis elegans PAR (partitioning-defective) proteins (from PAR1 to PAR6), which are essential for the formation of anterior-posterior asymmetry in the C. elegans embryo, and mammalian orthologs of Drosophila tumor suppressors such as Lethal giant larvae (Lgl), Discs large (Dlg) and Scribble (Scrib) (Kemphues et al., 1988; Tepass et al., 2001; Macara, 2004; Suzuki and Ohno, 2006) . In mammalian epithelial cells, atypical protein kinase C (aPKC) complexed with PAR3 and PAR6 (aPKC/PAR3/PAR6 complex) localizes and determines the apical membrane domain ( Figure 2a ). Their function is antagonized by PAR1 as well as a set of tumor suppressor proteins (Lgl, Dlg and Scrib) that localize In epithelial cells, PAR1 kinase localizes to the basolateral membrane, whereas atypical PKC complexed with PAR3 and PAR6 (aPKC complex) localizes to and above the tight junctions. Asymmetric distribution of PAR1 and the aPKC complex maintains the epithelial apical-basolateral polarity. At the tight junctions, aPKC phosphorylates PAR1, which induces dissociation of PAR1 from the membrane, and thereby prevents the distribution of PAR1 to the apical membrane domain. (b) Sequential interaction of CagA with PAR1 kinase and SHP-2 phosphatase. Two CagA proteins bind a PAR1 dimer through the CM sequences and specifically inhibit the PAR1 kinase activity. PAR1-dimerized CagA proteins then undergo tyrosine phosphorylation at the EPIYA segments by Src kinases, and the resulting tyrosine-phosphorylated CagA-PAR1 complex acquires the ability to stably interact with the SHP-2 oncoprotein containing two SH2 domains. (c) Upon delivery into gastric epithelial cells, CagA binds and inhibits PAR1 throughout the basolateral membrane, thereby disrupting tight junctions and inducing loss of epithelial apical-basolateral polarity. In cells that lost epithelial polarity, CagA elicits aberrant mitogenic signal as well as elevated cell motility upon deregulation of SHP-2. CagA, cytotoxin-associated gene A; CM, CagA multimerization; PKC, protein kinase C.
Linking epithelial polarity and carcinogenesis by H. pylori CagA M Hatakeyama and determine the basolateral membrane domain (for review see Humbert et al., this issue) . The apical and basolateral membrane domains are separated by a physical barrier termed the apical junctional complex comprising tight junctions and adherens junctions. Tight junctions establish and maintain cell polarity by limiting the diffusion of integral membrane proteins between apical and basolateral membranes. Tight junctions also generate a seal between the membranes of neighboring cells and act as a paracellular barrier of the polarized epithelial monolayer.
CagA colocalizes with tight junction proteins such as ZO-1 and JAM and causes disruption of the tight junction in polarized epithelial cells in a manner that is independent of CagA tyrosine phosphorylation (Amieva et al., 2003) . As a result, epithelial cells expressing CagA lose cell polarity, which is concomitantly associated with pseudopodia formation and degradation of the basement membrane (Bagnoli et al., 2005) . Hence, CagA induces cellular changes that resemble the epithelial-tomesenchymal transition. This CagA activity is mediated by specific interaction of CagA with PAR1 (Saadat et al., 2007 : Zeaiter et al., 2008 (Figure 1) , one of the six PAR proteins isolated in C. elegans. PAR1 is a serine/ threonine kinase that has a central function in the establishment and maintenance of the basolateral membrane domain in epithelial cells (Hurov et al., 2004; Suzuki et al., 2004) (Figure 2a ). Mammalian PAR1 was originally identified as a microtubule affinityregulating kinase (MARK) based on its ability to phosphorylate MAPs such as tau, MAP2 and MAP4 (Drewes et al., 1997) . Upon phosphorylation, PAR1 destabilizes microtubules by releasing MAPs from the microtubules. There are four PAR1 paralogs in mammalian cells, PAR1a/MARK3/C-TAK1, PAR1b/MARK2/ EMK, PAR1c/MARK1 and PAR1d/MARK4/MARKL1, which may have both shared and unique functions. Considering the fact that cell polarity is established by the concerted activity of asymmetrically localized proteins/protein complexes and the fact that microtubules serve as tracks for regulated movement of such proteins/protein complexes, PAR1 may regulate cell polarity at least partly through controlling the stability of microtubules by acting as a MARK.
CagA interacts with the kinase catalytic domain of PAR1, from PAR1a to PAR1d, and thereby inhibits PAR1 kinase activity (Saadat et al., 2007) (Figure 1) . Conversely, PAR1 binds to the C-terminal 16-aminoacid sequence of CagA known as the CagA-multimerization sequence (Ren et al., 2006) (Figure 1 ). As PAR1 is present as a dimer (Panneerselvam et al., 2006) , two CagA proteins passively dimerize upon interacting with a PAR1 dimer and, following tyrosine phosphorylation by Src, the PAR1-mediated CagA dimer forms a stable complex with a single SHP-2 molecule through the two SH2 domains of SHP-2 (Figure 2b ). Inhibition of PAR1 by CagA causes junctional and polarity defects, which are followed by disorganization of the epithelial monolayer (Figure 2c) . Interestingly, induction of the hummingbird phenotype by CagAderegulated SHP-2 requires simultaneous inhibition of the PAR1 kinase activity by CagA (Saadat et al., 2007) . The observation indicates that the phosphorylation-dependent CagA activity is also dependent on the phosphorylation-independent CagA activity.
Targeting E-cadherin/b-catenin complex by CagA Epithelial cell-cell adhesion is provided by the homophilic interaction of E-cadherin at the adherens junctions. The cytoplasmic domain of E-cadherin also interacts with a variety of peripheral membrane proteins, including p120 ctn , b-catenin, a-catenin, vinculin and a-actinin, and is associated with the actin cytoskeleton through these proteins. Besides acting as a cell-cell interaction apparatus, E-cadherin functions as an inhibitor of the b-catenin signal by preventing the function of b-catenin as a transcriptional factor by sequestrating it to the plasma membrane. Direct connection between E-cadherin and gastric carcinogenesis has been demonstrated through the finding that genetic mutations in CDH1, the gene encoding E-cadherin, are associated with hereditary diffuse gastric cancer (Guilford et al., 1998) . It is also well established that deregulated b-catenin signaling has an important function in the development of colorectal carcinoma (Segditsas and Tomlinson, 2006) .
Recent studies indicate a relationship between CagA and the E-cadherin/b-catenin complex. A carcinogenic H. pylori strain in Mongolian gerbils shows the ability to selectively activate b-catenin-dependent transcription in a CagA-dependent manner (Franco et al., 2005) . Activation of the b-catenin signal by CagA is independent of CagA tyrosine phosphorylation and is mediated by the interaction of CagA with E-cadherin, which leads to destabilization of the E-cadherin/bcatenin complex and thereby causes nuclear translocalization of otherwise membranous b-catenin to activate transcription . Thus, CagA impairs adherens junctions and at the same time elicits deregulated b-catenin signaling. Deregulation of b-catenin by CagA again requires the CagAmultimerization sequence to which PAR1 binds, indicating that the CagA-E-cadherin interaction is indirect and is mediated through the CagA-PAR1 complex (Kurashima et al., 2008) . Possibly, the CagA-PAR1 complex attracts a number of additional cellular proteins other than SHP-2 (Figure 2b ). One such protein may be E-cadherin and the interaction could destabilize the E-cadherin/b-catenin complex. CagAderegulated b-catenin transactivates several genes including cdx1, which encodes an intestine-specific transcription factor, Cdx1, that mediates intestinal differentiation . This observation raises the possibility that the CagA-deregulated b-catenin is involved in the development of intestinal metaplasia, a precancerous transdifferentiation of gastric epithelial cells to an intestinal phenotype (Correa, 1992) .
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Function of CagA-SHP-2 interaction in tumorigenesis
The recent establishment of transgenic mice that systemically express CagA has provided convincing evidence for the in vivo function of CagA as a bacterial oncoprotein (Ohnishi et al., 2008) . The cagA-transgenic mice developed gastric epithelial hyperplasia, gastric hyperplastic polyps and gastrointestinal carcinomas without showing any signs of inflammation, indicating that the oncogenic potential of CagA is cell autonomous. Importantly, the levels of CagA in transgenic mice established were far lower than those achieved by infection with H. pylori. Given that deregulated hyperactivation of SHP-2 is embryonically lethal (Araki et al., 2004) , overexpression of CagA would not be tolerated during mouse development. A portion of the cagAtransgenic mice also developed hematological malignancies, especially myeloid leukemias and B-cell lymphomas. The study using these mice further demonstrated the critical function of CagA tyrosine phosphorylation in the development of tumors in vivo. As CagA tyrosine phosphorylation is an essential prerequisite for CagA-SHP-2 interaction and subsequent deregulation of SHP-2 by CagA, the results of the work using these mice suggest a critical function for CagA-deregulated SHP-2 in tumorigenesis. Indeed, there is accumulating evidence that SHP-2 plays an important role in the development of human malignancies. Germline gain-of-function mutations of PTPN11, the gene encoding SHP-2, are associated with Noonan syndrome, a developmental disorder caused by the deregulated activation of the Ras-MAP kinase pathway (Tartaglia et al., 2001; Bentires-Alj et al., 2006) . Notably, Noonan patients exhibit increased risk of malignancies, especially juvenile myelomonocytic leukemia and neuroblastoma. Furthermore, PTPN11 mutations have been found in sporadic cases of juvenile myelomonocytic leukemia, childhood myelodysplastic syndrome, acute B-lymphocytic leukemia and acute myelocytic leukemia as well as some solid tumors such as neuroblastoma (Tartaglia et al., 2003; Bentires-Alj et al., 2004) . Hence, SHP-2 is a bona fide human oncoprotein like Ras (Mohi and Neel, 2007) . Notably, the spectrum of human hematological malignancies associated with SHP-2 mutation is similar to that observed in cagA-transgenic mice. Together with the observation that mice expressing disease-associated PTPN11 mutants also developed similar hematological abnormalities (Araki et al., 2004; Mohi et al., 2005) , CagA-deregulated SHP-2 may have a major function in the development of hematological malignancies in cagAtransgenic mice. It should be noted here that gastric mucosa-associated lymphoid tissue lymphoma, which is also associated with chronic infection with cagA-positive H. pylori, is derived from B lymphocytes, thereby suggesting a possible involvement of CagA in the development of mucosa-associated lymphoid tissue lymphoma.
Function of PAR1 in carcinogenesis
Although the CagA-SHP-2 oncoprotein interaction has an important function in cell transformation, it does not seem to be sufficient for the development of epithelial tumors (carcinomas), as transgenic expression of a gainof-function SHP-2 mutant in mice resulted in the development of hematological malignancies but not solid tumors (Araki et al., 2004) . This in turn indicates that the development of epithelial tumors requires both tyrosine phosphorylation-dependent and -independent CagA activities, suggesting a function for the CagA-PAR1 interaction in this process. Physiologically, PAR1 kinases are activated by phosphorylation of the T-loop on a threonine residue. This phosphorylation is carried out by another serine/threonine kinase, LKB1 (Lizcano et al. (2004) ; for review see Bardeesy et al., this issue). Germline loss-of-function mutations in the LKB1 gene are responsible for autosomal dominant Peutz-Jeghers syndrome, which is characterized by the development of benign hamartomatous polyps throughout the gastrointestinal tract (Hemminki et al., 1998) . One of the most important features associated with Peutz-Jeghers syndrome is the increased risk of carcinomas from the stomach, colon, lung, uterus and breast. These observations indicate that LKB1 is a tumor suppressor acting upstream of PAR1. Indeed, LKB1 is a mammalian ortholog of C. elegans PAR4 and is involved in polarity regulation in mammalian cells (Baas et al., 2004) . The causal link between LKB1 and the cancer-prone PeutzJeghers syndrome supports the idea that defects in epithelial polarity are required for the development of epithelial tumors. PAR1 is also phosphorylated by the aPKC/PAR3/PAR6 complex (Hurov et al., 2004; Suzuki et al., 2004) . This PAR1 phosphorylation creates a docking site for 14-3-3, the mammalian ortholog of C. elegans PAR5. Subsequent interaction of PAR1 with 14-3-3 dissociates PAR1 from the plasma membrane, thereby preventing the distribution of PAR1 to the apical membrane domain. Gene amplification and elevated activity of aPKC, which downregulates PAR1 functions, have also been reported in ovarian, lung and colon carcinomas (Murray et al., 2004; Eder et al., 2005; Regala et al., 2005) .
In addition to MAPs, PAR1a (MARK3/C-TAK1) has been reported to phosphorylate CDC25c phosphatase, which dephosphorylates and activates cyclin B/CDC2 to promote G2/M transition and subsequent M-phase progression. Upon phosphorylation by PAR1a, Cdc25c creates a docking site for 14-3-3 that sequestrates Cdc25c to the cytoplasm (Peng et al., 1998) . Similarly, PAR1a-mediated phosphorylation of the kinase suppressor of Raf-1, which potentiates the Ras-MAP kinase signaling as a scaffold, generates a 14-3-3 binding site and thereby inhibits kinase suppressor of Raf-1 activity (Muller et al., 2001) . Thus, PAR1a is capable of inhibiting cell multimerization at variable cell cycle phases. This in turn indicates that the inhibition of PAR1 kinases by CagA can directly stimulate cell proliferation.
Loss of epithelial polarity in cell transformation
Growing evidence supports the idea that impaired cell polarity is not only associated with the acquisition of Linking epithelial polarity and carcinogenesis by H. pylori CagA M Hatakeyama more malignant phenotypes such as metastatic potential but also involved in early stages of carcinogenesis. In Drosophila, mutations in the neoplastic tumor suppressor genes, lgl, dlg and scrib, disrupt polarity of epithelia and simultaneously induce overproliferation of epithelial cells with malignant characteristics, indicating the function of the fly tumor suppressors in coupling cell polarity and cell proliferation (Humbert et al., 2003; Bilder, 2004; Humbert et al., this issue) . Consistent with this idea, decreased expression of Lgl, Dlg or Scrib is observed in a variety of human tumors (Cavatorta et al., 2004; Nakagawa et al., 2004; Schimanski et al., 2005; Kuphal et al., 2006) . Furthermore, Dlg and Scrib are targeted for ubiquitin-mediated degradation by the high-risk human papillomavirus E6 oncoprotein, which is associated with cervical carcinoma, and also by the human T-cell leukemia virus type 1 tax oncoprotein (Kiyono et al., 1997; Lee et al., 1997; Gardiol et al., 1999; Suzuki et al., 1999; Nakagawa and Huibregtse, 2000) . How could loss of epithelial polarity promote cell transformation? Physiologically, the establishment of apical junctional complexes is a prerequisite for contact inhibition. This again indicates that coordinated regulation of cell polarity and cell growth has an important function in the prevention of uncontrolled cell proliferation. If transformed cells cannot form apical junctional complexes with 'normal' neighboring cells, they are excluded from the polarized epithelial monolayer and acquire the ability to initiate abnormal proliferation in the absence of growth inhibitory cues, which may otherwise be generated through epithelial cell-cell interaction. In this regard, the CagA-PAR1-SHP-2 complex has a dual function; disruption of the epithelial polarity and aberrant activation of the Ras-MAPK pathway, indicating that the protein complex coordinates cell polarity defects and oncogenic signaling to promote epithelial cell transformation (Saadat et al., 2007) . Such functional cooperativity has already been indicated by the observation that tumors induced by an oncogenic Ras in Drosophila do not have metastatic potential, whereas those induced by oncogenic Ras under the condition of loss of heterozygosity for lgl, dlg and scrib show more malignant phenotypes and frequently metastasize (Brumby and Richardson, 2003; Pagliarini and Xu, 2003) .
Many of the genes involved in epithelial cell polarity are also involved in the establishment and maintenance of polarity in stem cells (Betschlinger and Knoblich, 2004) . In particular, the function of PAR1 in the regulation of microtubules suggests that it could play a role in asymmetric cell division during mitosis. It is therefore possible that defects in the asymmetric division of epithelial stem cells by CagA-mediated PAR1 inhibition lead to an increased number of stem cells and thereby increase the chance of subsequent tumor development due to excess cell proliferation in the epithelial compartment.
Conclusion: multistep gastric carcinogenesis
The study of cagA-transgenic mice indicates that CagAmediated tumorigenesis is cell autonomous in that it neither requires additional bacterial factors nor elicits host responses such as inflammation (Ohnishi et al., 2008) . Why does CagA have an oncogenic potential? In other words, what is the advantage for H. pylori to have the CagA oncoprotein? Making a carcinoma in the host stomach may not be the primary purpose of cagApositive H. pylori. CagA per se does not confer growth advantage on H. pylori in vitro. Possibly, the presence of CagA enables H. pylori to colonize more successfully than cagA-negative H. pylori in the host stomach. In this context, the bacterium may utilize the oncogenic (abnormal mitogenic) signal triggered by CagA to gently but efficiently induce senescence or apoptosis/programmed cell death through the mechanism known as the 'oncogenic stress' (Ben-Porath and Weinberg, 2005; Prieur and Peeper, 2008) . This results in a decreased number of acid-secreting cells and thereby lowers gastric acidity to a level that provides a comfortable living environment for H. pylori.
Development of gastric adenocarcinoma is a multistep process that requires qualitative as well as quantitative alterations in the expression of oncogenes and tumor suppressor genes, lasting for several decades. During infection with cagA-positive H. pylori, gastric epithelial cells are continuously exposed to injection of CagA from the bacterium. The injected CagA binds and deregulates SHP-2 oncoprotein, while disrupting apical junctional complexes by interacting with PAR1, to induce oncogenic stress and subsequent apoptosis in gastric epithelial cells as noted above. This in turn causes elevated epithelial (stem) cell turnover and thereby increases the chance for gastric epithelial cells to acquire genetic and/or epigenetic changes in cancerrelated genes such as p53, ras, b-catenin, APC and RUNX3. Although the oncogenic potential of CagA appears to be cell autonomous, the process of tumor development may be greatly enhanced in the presence of chronic inflammation caused by H. pylori infection (Rieder et al., 2005) . In gastric epithelial cells that have acquired mutations in pro-apoptotic genes, CagA injection may provoke abnormal proliferation rather than induce apoptosis by oncogenic stress, thereby selectively and effectively expanding such precancerous cells. In this scenario, therefore, gastric cancer is a long-term side effect of the sustained oncogenic stress by CagA. Interestingly, chronic infection with cagApositive H. pylori induces aberrant expression of activation-induced cytidine deaminase, a key enzyme that generates antibody diversification, in a manner that is dependent on nuclear factor-kB (Matsumoto et al., 2007) . Activation-induced cytidine deaminase upregulation may significantly increase the chance of introducing somatic mutations in genes such as p53 and other genes involved in gastric carcinogenesis.
